Difference between revisions of "Pentamidine (Nebupent)"
m (Text replace - "package insert<ref name="insert"></ref>." to "prescribing information.<ref name="insert"></ref>") |
|||
| Line 1: | Line 1: | ||
| − | |||
| − | |||
==General information== | ==General information== | ||
Class/mechanism: Antifungal, known to have activity against Pneumocystis jiroveci. Mechanism not fully understood, but mechanism hypothesized to involve inhibition of DNA, RNA, phospholipid, and protein synthesis.<ref name="insert">[http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019887s014lbl.pdf Pentamidine (Nebupent) package insert]</ref><ref>[http://hemonc.org/docs/packageinsert/pentamidine.pdf Pentamidine (Nebupent) package insert (locally hosted backup)]</ref> | Class/mechanism: Antifungal, known to have activity against Pneumocystis jiroveci. Mechanism not fully understood, but mechanism hypothesized to involve inhibition of DNA, RNA, phospholipid, and protein synthesis.<ref name="insert">[http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019887s014lbl.pdf Pentamidine (Nebupent) package insert]</ref><ref>[http://hemonc.org/docs/packageinsert/pentamidine.pdf Pentamidine (Nebupent) package insert (locally hosted backup)]</ref> | ||
| Line 10: | Line 8: | ||
==Patient drug information== | ==Patient drug information== | ||
*[http://www.uptodate.com/contents/pentamidine-patient-drug-information Pentamidine (Nebupent) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/pentamidine-patient-drug-information Pentamidine (Nebupent) patient drug information (UpToDate)]</ref> | *[http://www.uptodate.com/contents/pentamidine-patient-drug-information Pentamidine (Nebupent) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/pentamidine-patient-drug-information Pentamidine (Nebupent) patient drug information (UpToDate)]</ref> | ||
| + | |||
| + | ==Also known as== | ||
| + | Benambax, Lomidine, Nebupent, Pentam, Pentam 300, Pentamidina Combino, Pentamidina Combinopharm, Pentamidina Filaxis, Pentamidina Richet, Pentamidine Dimesilate, Pentamidine Isethi, Pentamidine Isethionate, Pneumopent | ||
==References== | ==References== | ||
<references/> | <references/> | ||
Revision as of 20:30, 3 April 2013
General information
Class/mechanism: Antifungal, known to have activity against Pneumocystis jiroveci. Mechanism not fully understood, but mechanism hypothesized to involve inhibition of DNA, RNA, phospholipid, and protein synthesis.[1][2]
Route: inhaled, IM, IV
Extravasation: no information
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Patient drug information
Also known as
Benambax, Lomidine, Nebupent, Pentam, Pentam 300, Pentamidina Combino, Pentamidina Combinopharm, Pentamidina Filaxis, Pentamidina Richet, Pentamidine Dimesilate, Pentamidine Isethi, Pentamidine Isethionate, Pneumopent